Skip to main navigation
  • Investors
    • Overview
    • News & Events
    • Stock
    • Corporate Governance
    • Financial Information
    • Shareholder Services
  • Careers
  • Contact Us
Veradermics, Inc. corp site
  • About Us
    • Overview
    • Our Team
    • Board of Directors
  • Our Approach
  • Our Pipeline
    • Overview
    • Pattern Hair Loss
  • About VDPHL01
  • Clinical Trials
  • About Us
    • Overview
    • Our Team
    • Board of Directors
  • Our Approach
  • Our Pipeline
    • Overview
    • Pattern Hair Loss
  • About VDPHL01
  • Clinical Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Financial Information
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Information Request
  • Careers
  • Contact Us

SEC Filing Details

  • Overview
  • News & Events
  • Stock
  • Corporate Governance
  • Financial Information
  • Shareholder Services
  • SEC Filings
Document Details
Form
SCHEDULE 13D
Filing Date
Feb 11, 2026
Document Date
Feb 11, 2026
Form Description
SCHEDULE 13D - Description
Filing Group
Other
Company
Veradermics, Inc.
Issuer
VERADERMICS, INC
Filing Formats
View HTML
Download PDF
Download DOC
Download XLS
Veradermics, Inc. footer logo

470 James St., Suite 14
New Haven, CT 06513

 

+1.22.VERA.DERM
(+1.228.372.3376)

twitter twitter twitter
  • About Us
  • Our Approach
  • Our Pipeline
  • Clinical Trials
  • Investors
  • Careers
  • Contact Us

Veradermics is on a mission to make long-ignored dermatology and aesthetics conditions simple — replacing false hope, confusion, and questionable results with solutions that people and providers can trust.

© 2026 Veradermics, Inc. All Rights Reserved .

  • Terms of Use
  • Privacy Policy
  • Washington State Privacy